Notably, NEAT1 silencing impeded tumour growth and decreased expression levels of Ki‐67, DNMT1 and mTOR, whereas it concurrently increased miR‐185‐5p expression in an in vivo setting. The gene discussed is DNMT1; the disease is neoplasm.